Opportunities in precision psychiatry using PET neuroimaging in psychosis

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


With the movement toward precision medicine in healthcare, recent studies of individuals with psychosis have begun to explore positron emission tomography (PET) as a tool to test for biochemical signatures that may distinguish subtypes of psychosis that guide subtype-specific therapeutic interventions. This review presents selected PET findings that exemplify early promise in using molecular imaging to predict treatment response, provide rationale for new therapeutic targets, and monitor target engagement in biomarker-defined subtypes of psychosis. PET data, among other data types, may prove useful in the scientific pursuit of identifying precision strategies to improve clinical outcomes for individuals with psychosis.

Original languageEnglish (US)
Article number104428
JournalNeurobiology of Disease
StatePublished - Nov 2019


  • Dopamine
  • Neuroimmunity
  • PET imaging
  • Precision medicine
  • Psychosis
  • alpha7 nicotinic acetylcholine receptor

ASJC Scopus subject areas

  • Neurology


Dive into the research topics of 'Opportunities in precision psychiatry using PET neuroimaging in psychosis'. Together they form a unique fingerprint.

Cite this